Pfizer Inc. has filed its annual Form 11-K report with the SEC for the fiscal year ended December 31, 2023, detailing the financial status of the Pfizer Savings Plan for Employees Resident in Puerto Rico. The independent audit, conducted by KPMG LLP, affirms that the financial statements present a fair view of the Plan's net assets and changes in net assets, in accordance with U.S. GAAP. The Plan's net assets available for benefits decreased from $396.2 million in 2022 to $385.8 million in 2023. The report includes a comprehensive breakdown of the Plan's investments, which are primarily in Pfizer common stock, common/collective trust funds, and mutual funds. The Plan is a defined contribution plan open to eligible employees of PBG Puerto...Show More

Pfizer Inc. has filed its annual Form 11-K report with the SEC for the fiscal year ended December 31, 2023, detailing the financial status of the Pfizer Savings Plan for Employees Resident in Puerto Rico. The independent audit, conducted by KPMG LLP, affirms that the financial statements present a fair view of the Plan's net assets and changes in net assets, in accordance with U.S. GAAP. The Plan's net assets available for benefits decreased from $396.2 million in 2022 to $385.8 million in 2023. The report includes a comprehensive breakdown of the Plan's investments, which are primarily in Pfizer common stock, common/collective trust funds, and mutual funds. The Plan is a defined contribution plan open to eligible employees of PBG Puerto Rico LLC and affiliates, subject to ERISA and the Puerto Rico Code. Contributions are matched by the company up to a certain percentage, and the Plan includes a Retirement Savings Contribution based on age and years of service. The Plan's investments are managed by various parties including Banco Popular de Puerto Rico, Northern Trust, Fidelity, and SSGA, all considered related parties or parties-in-interest. The Plan's tax status is in compliance with the Puerto Rico Code, and no uncertain tax positions require disclosure. The Plan is subject to the usual risks associated with investment securities, and its assets will not revert to the company except as permitted under ERISA.